CAS 145258-61-3: interferon beta

Description: Interferon beta is a glycoprotein that plays a crucial role in the immune response, particularly in the regulation of antiviral activity and modulation of immune system functions. It is classified as a type of interferon, which are signaling proteins produced by host cells in response to viral infections and other stimuli. Interferon beta is primarily produced by fibroblasts and has been extensively studied for its therapeutic applications, particularly in the treatment of multiple sclerosis, where it helps to reduce inflammation and slow disease progression. The substance exhibits antiviral properties by enhancing the activity of immune cells and promoting the expression of genes that inhibit viral replication. Interferon beta is typically administered via injection and can have side effects, including flu-like symptoms, injection site reactions, and potential impacts on liver function. Its molecular structure includes a specific arrangement of amino acids, contributing to its biological activity and interaction with cell surface receptors. Overall, interferon beta is a vital component in immunotherapy and continues to be an area of active research for various diseases.

Formula: C₉₀₈H₁₄₀₆N₂₄₆O₂₅₂S₇

Synonyms:

• Interferon beta-1a [USAN:INN:BAN]
• Interferon beta 1a
• Avonex
• Neoferon
• Recombinant human interferon beta 1a
• Unii-Xro4566Q4R
• Interferon beta1 (human fibroblast protein moiety)

Interferon β-1a CRS

CAS: 145258-61-3

Interferon β-1A for Bioidentity

CAS: 145258-61-3

Immunological products, mixed, not put up in measured doses or in forms or packings for …

• Formula: C₉₀₈H₁₄₀₆N₂₄₆O₂₅₂S₇
• Color and Shape: Light Yellow Liquid
• Molecular weight: 20012.28118

Interferon β-1A

CAS: 145258-61-3

Immunological products, unmixed, not put up in measured doses or in forms or packings for …

• Formula: C₉₀₈H₁₄₀₆N₂₄₆O₂₅₂S₇(proteinmoiety)
• Color and Shape: Pale Yellow Liquid
• Molecular weight: 20012.28118